4/A: OEP Entities Boost AdaptHealth Stake

One Equity Partners entities, including OEP VII GP, L.L.C., amended a filing to reflect significant common stock purchases in AdaptHealth Corp. totaling over 2 million shares.

Summary

• OEP VII GP, L.L.C. and related One Equity Partners entities (collectively, the "OEP Entities") filed an amendment to a previous Form 4.
• The amendment clarifies that the OEP Entities are the reporting persons and direct/indirect holders of AdaptHealth Corp. (AHCO) common stock.
• The original Form 4 was filed by Richard Cashin on March 12, 2026, and this amendment corrects the reporting persons due to Edgar filing codes not being available previously.
• The OEP Entities acquired a total of 2,046,691 shares of AdaptHealth Corp. common stock across three transactions in March 2026.
• On March 10, 2026, 820,528 shares were purchased at a weighted average price of $9.7287 per share, with prices ranging from $9.58 to $9.95.
• On March 11, 2026, 536,827 shares were purchased at a weighted average price of $9.7281 per share, with prices ranging from $9.64 to $9.75.
• On March 12, 2026, 689,336 shares were purchased at a weighted average price of $9.7299 per share, with prices ranging from $9.55 to $9.75.
• Following these transactions, the OEP Entities beneficially own 15,864,871 shares of AdaptHealth Corp. common stock indirectly.
• Richard Cashin, a director and 10% owner, is deemed to have voting and investment discretion over these securities.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal due to substantial insider buying by a significant institutional investor and director, indicating high confidence in AdaptHealth Corp.'s valuation and future outlook, despite a minor compliance correction.

Positives

• Significant insider buying by a 10% owner and director group, totaling over 2 million shares, indicates strong confidence in AdaptHealth Corp.'s future prospects.
• The purchases were made at an average price around $9.73, suggesting the reporting persons see value at or above these levels.
• The transactions were executed under a Rule 10b5-1(c) plan, which can signal a pre-meditated investment strategy rather than opportunistic trading.

Negatives

• The amendment itself highlights an initial compliance issue where the correct reporting persons were not fully disclosed in the original filing, although this has now been rectified.

Risks

• No explicit company-specific risks are detailed, as the document primarily reports on insider transactions.
• General market risks and company-specific operational risks for AdaptHealth Corp. are not addressed.

Future Outlook

No forward-looking statements or guidance regarding AdaptHealth Corp.'s future performance or strategic direction are provided, as the document focuses solely on past insider transactions.

Management Comments

• Richard Cashin, a director and 10% owner, is deemed to have voting and investment discretion over the reported securities.

Industry Context

StockSavvy.ai notes that significant insider buying by a major institutional investor and director, such as One Equity Partners, often signals strong internal conviction about a company's valuation and future prospects, particularly in the healthcare services sector where AdaptHealth operates. This can be interpreted by the market as a positive indicator, suggesting that those with deep knowledge of the company believe its shares are undervalued or poised for growth.

Comparison to Industry Standards

• StockSavvy.ai observes that insider purchases of this magnitude (over 2 million shares) by a 10% owner are substantial and typically viewed more favorably than smaller, routine insider transactions.
• While direct comparisons to specific competitor insider buying are not provided in the filing, such a move by a private equity firm like One Equity Partners, known for its strategic investments, often aligns with a long-term value creation thesis, similar to large institutional buys seen in companies like Encompass Health or LHC Group within the post-acute care space, indicating a belief in the underlying business fundamentals.

Related Party Transactions

• The reported transactions constitute related party dealings, involving a 10% owner and director (Richard Cashin and the OEP Entities he controls) purchasing shares of the issuer.

Stakeholder Impact

• Shareholders: Existing shareholders may view the significant insider buying as a positive indicator of future stock performance and management confidence, potentially increasing investor sentiment.

Next Steps

• The reporting persons undertake to provide full information regarding the number of shares purchased at each separate price within the reported ranges upon request to AdaptHealth Corp., any security holder, or the SEC staff.

Key Dates

Recommendation

The substantial insider buying by One Equity Partners, a sophisticated institutional investor and 10% owner, coupled with the director Richard Cashin's oversight, signals strong conviction in AdaptHealth Corp.'s intrinsic value and future growth prospects. Such a significant investment at current price levels suggests these informed parties believe the stock is undervalued, making it an attractive 'buy' for seasoned investors.

Keywords

AdaptHealth Corp, AHCO, One Equity Partners, OEP VII GP, Insider Buying, Stock Purchase, Form 4/A, Beneficial Ownership, Director, 10% Owner, Rule 10b5-1, Equity Investment